Literature DB >> 30666475

Report on a child with neurofibromatosis type 2 and unilateral moyamoya: further evidence of cerebral vasculopathy in NF2.

Claudia Santoro1, Federica Palladino2, Pia Bernardo3, Giuseppe Cinalli4, Giuseppe Mirone4, Teresa Giugliano5, Giulio Piluso5, Silverio Perrotta2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30666475     DOI： 10.1007/s10072-019-3728-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.

Authors:  Hon-Kit Wong; Akio Shimizu; Nathaniel D Kirkpatrick; Igor Garkavtsev; Annie W Chan; Emmanuelle di Tomaso; Michael Klagsbrun; Rakesh K Jain
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

2.  Regulation of merlin by protein phosphatase 1-TIMAP and EBP50 in endothelial cells.

Authors:  Anita Boratkó; Margit Péter; Csilla Csortos
Journal:  Int J Biochem Cell Biol       Date:  2016-11-18       Impact factor: 5.085

3.  Cerebral vasculopathy in childhood neurofibromatosis type 2: cause for concern?

Authors:  Karine Lascelles; Shazia Afridi; Ata Siddiqui; Cheryl Hemingway; Rosalie Ferner; Vijeya Ganesan
Journal:  Dev Med Child Neurol       Date:  2018-05-21       Impact factor: 5.449

4.  Further genotype--phenotype correlations in neurofibromatosis 2.

Authors:  S K Selvanathan; A Shenton; R Ferner; A J Wallace; S M Huson; R T Ramsden; D G Evans
Journal:  Clin Genet       Date:  2009-11-23       Impact factor: 4.438

5.  Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation.

Authors:  Katrina A Morris; John F Golding; Patrick R Axon; Shazia Afridi; Claire Blesing; Rosalie E Ferner; Dorothy Halliday; Raj Jena; Pieter M Pretorius; D Gareth Evans; Martin G McCabe; Allyson Parry
Journal:  Neurooncol Pract       Date:  2016-01-07
  5 in total
  2 in total

1.  Rare Neurologic Diseases and Neurological Sciences: a report for the celebration of the 2020 Rare Diseases Day.

Authors:  Antonio Federico
Journal:  Neurol Sci       Date:  2020-03       Impact factor: 3.307

Review 2.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.